David M Goldenberg

Summary

Country: USA

Publications

  1. pmc The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression
    Daniela Frölich
    Department of Medicine, Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 14:R54. 2012

Detail Information

Publications1

  1. pmc The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression
    Daniela Frölich
    Department of Medicine, Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Chariteplatz 1, Berlin 10117, Germany
    Arthritis Res Ther 14:R54. 2012
    ..Therefore, the current study addressed the influence of milatuzumab on B-cell proliferation, chemo-attractant migration, and adhesion molecule expression...